Live feed08:30:00·15hSave storyPRReleasevia QuantisnowEvogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery ProgramByQuantisnow·Wall Street's wire, on your screen.EVGNEvogene LtdIndustrials